Diseases, Conditions, Syndromes

U.S. officials change virus risk groups, add pregnant women

The nation's top public health agency on Thursday revamped its list of which Americans are at higher risk for severe COVID-19 illness, adding pregnant women and removing age alone as a factor.

Oncology & Cancer

A metabolic enzyme drives lymphoma and is a potential drug target

Because of how aggressively they divide, cancer cells have an increased demand for building materials and energy. They meet these added demands by altering their metabolism—taking in larger amounts of fuel, for example.

Oncology & Cancer

Mystery about the cancer drug nelarabine solved after decades

Acute lymphoblastic leukemia (ALL) is the most common kind of cancer in children. T-ALL, a subtype that resembles T-lymphocytes, can be treated successfully with the drug nelarabine. The drug has not been successful, however, ...

Oncology & Cancer

Researchers attempt new treatment approach for blood cancer

In an effort to improve the survival of patients with myeloproliferative neoplasms, a type of leukemia, researchers inhibited a specific protein (alpha5beta1 integrin) to decrease the number of large bone marrow cells (megakaryocytes) ...

Genetics

Study links endometriosis to DNA changes

DNA from uterine cells of women with endometriosis has different chemical modifications, compared to the DNA of women who do not have the condition, according to researchers funded by the National Institutes of Health. The ...

Immunology

Antihypotensive agent disrupts the immune system in sepsis

Patients who go into septic shock are treated with the antihypotensive agent norepinephrine. Researchers from Radboud University Medical Center published results in today's American Journal of Respiratory and Critical Care ...

page 18 from 38